Standard BioTools Inc
NASDAQ:LAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Standard BioTools Inc
NASDAQ:LAB
|
US |
|
OneMain Holdings Inc
NYSE:OMF
|
US |
|
Trigano SA
PAR:TRI
|
FR |
|
O
|
Origin Enterprises PLC
LSE:OGN
|
IE |
|
Andromeda Metals Ltd
ASX:ADN
|
AU |
|
MLG OZ Ltd
ASX:MLG
|
AU |
|
T
|
Tompkins Financial Corp
AMEX:TMP
|
US |
|
Lovisa Holdings Ltd
F:LO7
|
AU |
|
SPS Commerce Inc
NASDAQ:SPSC
|
US |
|
First of Long Island Corp
NASDAQ:FLIC
|
US |
Wall Street
Price Targets
LAB Price Targets Summary
Standard BioTools Inc
According to Wall Street analysts, the average 1-year price target for
LAB
is 1.581 USD
with a low forecast of 1.3635 USD and a high forecast of 1.8375 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is LAB's stock price target?
Price Target
1.581
USD
According to Wall Street analysts, the average 1-year price target for
LAB
is 1.581 USD
with a low forecast of 1.3635 USD and a high forecast of 1.8375 USD.
What is Standard BioTools Inc's Revenue forecast?
Projected CAGR
1%
For the last 14 years the
compound annual growth rate for
Standard BioTools Inc's revenue is
5%.
The projected
CAGR
for the next 3 years is
1%.
